Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Ministry of Health, Brazil | OTHER_GOV |
Not provided
Not provided
Not provided
Not provided
This is a registry-based cohort study of all adult patients (≥18 years) with confirmed or suspected SARS-CoV-2 infection.
The main goal is to describe mortality incidence, demographic characteristics, coexisting conditions, treatments, outcomes among SARS-CoV2 infected patients.
A secondary goal is to identify biological factors (OMICS - genomic, proteomic and metabolomics characterization) associated with severity conditions for these patients.
Registry on characteristics and outcomes of hospitalized and non-hospitalized SARS-CoV2 infected patients in Brazil.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Hospitalized patients | Patient who are suspected or confirmed SARS-CoV2 infection need hospitalization. |
| |
| Non-hospitalized patients | Patient who are suspected or confirmed SARS-CoV2 infection non-hospitalized. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Hospital admission | Other | Usual care. |
| |
| Non-hospitalization procedures |
| Measure | Description | Time Frame |
|---|---|---|
| All-cause mortality | All-cause mortality rates at 60 days | 60 Days |
| Measure | Description | Time Frame |
|---|---|---|
| Incidence and course of symptoms of COVID-19 infection | To assess the prevalence and course of symptoms of COVID-19 infection of patients followed during a period of 60 days | 60 Days |
| Hospitalizations |
| Measure | Description | Time Frame |
|---|---|---|
| Serum proteomic | Percentual changes in serum proteome of patients with mild or moderate to severe disease | 60 Days |
| Serum metabolomic | Percentual changes in serum metabolome of patients with mild or moderate to severe disease |
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
SARS-Brazil Registry is designed as multicenter observational cohort of adult patients (≥18 years old), that are confirmed or suspected SARS-CoV-2 infection in Brazilian hospitals.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Otávio Berwanger, PhD | Hospital Israelita Albert Einstein | Study Director |
| Henrique A Fonseca, PhD | Hospital Israelita Albert Einstein | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Hospital de Emergencia Dr. Daniel Houly | Arapiraca | Alagoas | Brazil | |||
| Alencar Serviços Médicos Ltda |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 39140573 | Derived | Fonseca HAR, Pereira AJ, Nawa RK, Sant'Anna VAR, Almeida TF, Guimaraes HP, Tognon AP, Marques LM, Silva LSCD, Bittencourt RS, Gomes CP, Martins PA, Oliveira AL, Milan EP, Dall'Orto FTC, Hoffman Filho CR, Almeida G, Hohmann FB, Moia DDF, Piano LPA, Machado FP, Soares RVP, Damiani LP, Assis SRL, Amaro Junior E, Rizzo LV, Berwanger O. Mortality, hospitalizations, and persistence of symptoms in the outpatient setting of the first COVID-19 wave in Brazil: results of SARS-Brazil cohort study. Einstein (Sao Paulo). 2024 Aug 9;22:eAO0652. doi: 10.31744/einstein_journal/2024AO0652. eCollection 2024. |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Blood, serum, plasma and nasal swab
| Other |
Usual care. |
|
Rate of patients requiring hospitalization and re-hospitalization (readmission to the hospital occurring within 60 days after admission)
| 60 Days |
| Oxygen supplementation | Rate of patients requiring oxygen therapy | 60 Days |
| Use of invasive mechanical ventilation | Rate of patients requiring invasive mechanical ventilation | 60 Days |
| Intensive care unit length of stay | ICU length of stay | 60 Days |
| 60 Days |
| Genomic description | Determination of whole genome sequence and transcriptomic of mild or moderate to severe disease | 60 Days |
| Barbalha |
| Ceará |
| Brazil |
| Hospital Estadual Jayme dos Santos Neves | Serra | Espírito Santo | Brazil |
| Hospital Santa Rita de Cássia | Vitória | Espírito Santo | Brazil |
| Universidade Federal da Bahia | Vitória da Conquista | Estado de Bahia | Brazil |
| Fundação Educacional Lucas Machado | Belo Horizonte | Minas Gerais | Brazil |
| Fundação Hopitalar São Francisco de Assis | Belo Horizonte | Minas Gerais | Brazil |
| Hospital Santa Lucia | Poços de Caldas | Minas Gerais | Brazil |
| Hospital Giselda Trigueiro | Natal | Rio Grande do Norte | Brazil |
| Hospital São Vicente de Paulo | Passo Fundo | Rio Grande do Sul | Brazil |
| Santa Casa de Votuporanga | Votuporanga | São Paulo | Brazil |
| Hospital Municipal Vila Santa Catarina | São Paulo | Brazil |
| Hospital São Camilo - Ipiranga | São Paulo | Brazil |
| Hospital São Camilo - Pompéia | São Paulo | Brazil |
| ID | Term |
|---|---|
| D000086382 | COVID-19 |
| D045169 | Severe Acute Respiratory Syndrome |
| ID | Term |
|---|---|
| D011024 | Pneumonia, Viral |
| D011014 | Pneumonia |
| D012141 | Respiratory Tract Infections |
| D007239 | Infections |
| D014777 | Virus Diseases |
| D018352 | Coronavirus Infections |
| D003333 | Coronaviridae Infections |
| D030341 | Nidovirales Infections |
| D012327 | RNA Virus Infections |
| D008171 | Lung Diseases |
| D012140 | Respiratory Tract Diseases |
Not provided
Not provided